Skip to content

Cervical IgA (Immunoglobulin A) by Immunoassay (Qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of Immunoglobulin A (IgA), a type of antibody found in cervical fluid, often checked during certain gynecological evaluations.

Quick summary

["IgA in cervical fluid may help assess immune response or infection risk in reproductive health contexts."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
106127-4
Short code
Sperm IgA NFr Cervix IBT
Synonyms
Sperm IgA NFr Cervix IBT
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
immunobead
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like unusual vaginal discharge, pelvic pain, or if you’re at higher risk for infections (e.g., sexually transmitted infections, recurrent vaginal infections). It can also be part of screening for conditions like cervical dysplasia or immune-related disorders.

What to Expect Before the Test

No special preparation is needed. You’ll likely have a simple swab or fluid sample collected during a pelvic exam or cervical sampling procedure. Avoid douching or sexual activity 24 hours before the test to ensure accurate results.

What the Results Mean

A positive result indicates detectable IgA in cervical fluid, which could signal an immune response, infection, or other underlying condition. A negative result means no detectable IgA was found. Results should be interpreted by your provider in the context of your symptoms and medical history.

Common Reasons for Testing

This test is less commonly performed than others but may be used in specialized evaluations, such as assessing immune function in cervical samples, diagnosing certain infections, or monitoring chronic conditions affecting the cervix.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Limited but Context-Dependent

Short name

IgA in Cervical Fluid

Frequently asked questions

What Does This Test Measure?
This test specifically detects the presence of Immunoglobulin A (IgA) antibodies in cervical fluid, which can indicate localized immune activity or infection. IgA is part of the body’s immune defense and is often found in mucosal areas like the cervix.
How Might My Results Affect My Treatment?
If your results show abnormal IgA levels, your provider may recommend further testing (e.g., cultures, additional imaging) or treatments tailored to the suspected cause, such as antibiotics for infections or lifestyle adjustments for immune-related conditions.
Are There Any Risks or Side Effects?
There are generally no risks associated with this test, as it involves a simple sample collection. However, minor discomfort during the procedure is possible, and rare complications (e.g., infection) should be discussed with your healthcare provider.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy